EU must take the lead to ensure security of supply for medicines

16 June 2021

Legislative reforms aligned with current off-patent market conditions are the […]

Open borders that prioritise essential goods key to medicines supply in Europe

2 June 2021

EU Industrial strategy should be key to improving medicines supply chains

17 May 2021

The newly launched update of the industrial strategy aims to […]

“Off patent medicines essential for a fairer, healthier, and sustainable Europe” says President Christoph Stoller

30 April 2021

Christoph Stoller will speak at 3A CONFERENCE – Availability, Accessibility, […]

EU must address barriers to continuous off-patent innovation and grasp opportunity for patients and healthcare

23 February 2021

EU Pharma strategy provides unique moment to establish a regulatory […]

A new medicines trade and health security agenda for the European Commission

19 February 2021

In response to the European Commission Trade Communication published on […]

No further excuse to delay digital regulatory infrastructure for medicines after Covid-19 pandemic

19 February 2021

Smarter use of generic, biosimilar and value added medicines will ensure equitable access to cancer care

4 February 2021

AESGP, EFPIA and Medicines for Europe reflections on the European Medicines Agency, the Heads of Medicines Agencies and the European Commission “Key principles for the use of electronic product information for EU medicines” press release.

3 February 2021

Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks

19 January 2021